Prosecution Insights
Last updated: May 29, 2026

Pleechae Intellectual Property LLC

8 pending office actions • 7 clients • 8 examiners • 8 art units • 0 of 8 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
4
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
3
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (3)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
8
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only8 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
88% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
12% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MARSH, OWEN LEWIS 1
CHANG, KYUNG SOOK 1 60.3% +41.2%
FAY, ZOHREH ALEMZADEH 1 51.8% -6.7%
WELLES, COLMAN THOMAS 1 33.3% +76.9%
LANKFORD JR, LEON B 1 69.8% +31.0%
CHANDRA, GYAN 1 71.1% +27.7%
BARRERA, IMMACULADA 1 28.6% +83.3%
KAHN, RACHEL 1 27.6% +15.9%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18018618 ANTIVIRAL COMPOSITION AGAINST CORONAVIRUS BARRERA, IMMACULADA 25d overdue
17845493 POLYIMIDE COPOLYMER AND POLYIMIDE FILM USING THE SAME KAHN, RACHEL 1d overdue

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18018618 ANTIVIRAL COMPOSITION AGAINST CORONAVIRUS BARRERA, IMMACULADA 25d overdue
17845493 POLYIMIDE COPOLYMER AND POLYIMIDE FILM USING THE SAME KAHN, RACHEL 1d overdue
18681600 COMPOSITION FOR GENERATING NITROGEN MONOXIDE CHANG, KYUNG SOOK 9d
18375599 COMPOSITION FOR ENHANCING GROWTH OF PLANTS WELLES, COLMAN THOMAS 21d
18284239 COMPOSITION FOR ENHANCING PHYSIOLOGICAL EFFICACY OF LACTIC ACID BACTERIA LANKFORD JR, LEON B 39d
18024819 PEPTIDE, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME CHANDRA, GYAN

Client Portfolio (7 clients)

Top Art Units

Art UnitApps
37961
16131
16171
16121
16571
16741
16711
17661

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18678085 METHOD FOR DETECTING SIGNS OF ATRIAL FIBRILLATION IN NORMAL SINUS RHYTHM AND DEVICE THEREOF Chonnam National University Hospital MARSH, OWEN LEWIS 3796 §103 Non-Final OA 23d Pending May 30, 2024
18681600 COMPOSITION FOR GENERATING NITROGEN MONOXIDE Seoul National University R&Db Foundation CHANG, KYUNG SOOK 1613 §103 Non-Final OA 9d Pending Feb 06, 2024
18577404 MICELLE COMPLEX AND DRUG CARRIER COMPRISING SAME Dr. Cure Co., Ltd. FAY, ZOHREH ALEMZADEH 1617 §103 Non-Final OA 62d Pending Jan 08, 2024
18375599 COMPOSITION FOR ENHANCING GROWTH OF PLANTS Industry Foundation Of Chonnam National University WELLES, COLMAN THOMAS 1612 §103 Final Rejection 21d Pending Oct 02, 2023
18284239 COMPOSITION FOR ENHANCING PHYSIOLOGICAL EFFICACY OF LACTIC ACID BACTERIA Seoul National University R&Db Foundation LANKFORD JR, LEON B 1657 §103 Final Rejection 39d Pending Sep 26, 2023
18024819 PEPTIDE, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Seoul National University Hospital CHANDRA, GYAN 1674 §103 Final Rejection Pending Mar 06, 2023
18018618 ANTIVIRAL COMPOSITION AGAINST CORONAVIRUS Novelgen Co., Ltd. BARRERA, IMMACULADA 1671 §103 Final Rejection 25d overdue Pending Jan 30, 2023
17845493 POLYIMIDE COPOLYMER AND POLYIMIDE FILM USING THE SAME Jeonju University Office Of Industry-University Cooperation KAHN, RACHEL 1766 §103 Non-Final OA 1d overdue Pending Jun 21, 2022

Managing Pleechae Intellectual Property LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month